USI-founded fake news detection technology developer Fabula AI has been scooped up by Twitter, which will employ the spinout's talent to remove spam and abuse from its platform.

The immunotherapy technology developer has set a $230m target for an initial public offering that would offer exits to LabCorp, Illumina, Celgene and BD Biosciences.

Novo, GlaxoSmithKline, Pfizer, AbbVie, ShangPharma and Schrödinger are all in line for exits following the small-molecule drug developer's decision to file for an $86.3m initial public offering.

Raksul has exited custom printed product marketplace InkMonk in an acquisition of undisclosed size by Printo, with the deal reportedly creating India's largest printing services provider.

Bristol-founded haptics platform developer Ultrahaptics is set to absorb Leap Motion's patents and employees, succeeding in a transaction that Apple failed to complete twice.

Corporate venturing units GV, REV and MassMutual Ventures look set to exit the threat intelligence provider in a deal that values it at $780m.

Salesforce Ventures has exited the content marketing platform in an acquisition by Upland Software that follows some $22m in funding.

Dell Technologies Capital will exit container cybersecurity technology provider Twistlock in an acquisition by Palo Alto Networks that follows $63m of funding.

Mitsui has exited customer data platform developer Drawbridge, which was acquired by LinkedIn after raising a reported $70m in venture capital funding.

NetApp paid $70m to acquire the data protection software developer, which had raised $11m from investors including Prosegur.